ClinicalTrials.Veeva

Menu
O

Omni Fertility and Laser Institute | Shreveport, LA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Vilaprisan
MT-2990
OG-6219
Famciclovir

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain (ELENA)

The purpose of this global Phase 2 study is to determine the efficacy, safety, and tolerability of 3 dose levels of OG-6219 in pre-menopausal women b...

Enrolling
Endometriosis
Drug: Placebo
Drug: OG-6219

The study was performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care

Active, not recruiting
Uterine Fibroids
Drug: Vilaprisan (BAY1002670)
Other: Standard of care

Trial sponsors

Bayer logo
Mitsubishi Tanabe Pharma logo
Novartis logo
Organon logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems